瑞科生物－Ｂ：2022中期報告.pdf

1、Jiangsu Recbio Technology Co.,Ltd.江蘇瑞科生物技術股份有限公司INTERIM REPORT 2022 中期報告江蘇瑞科生物技術股份有限公司Jiangsu Recbio Technology Co.,Ltd.(a joint stock company incorporated in the Peoples Republic of China with limited liability)（於中華人民共和國註冊成立的股份有限公司）Stock Code：2179股份代號中期報告INTERIM REPORT20222Corporate Information公司資料

2、6Chairmans Statement主席致辭8Financial Highlights財務摘要9Management Discussion and Analysis管理層討論與分析40Other Information其他資料62Independent Review Report獨立審閱報告64Interim Condensed Consolidated Statement of Profit or Loss and Other Comprehensive Income中期簡明綜合損益及其他全面收益表65Interim Condensed Consolidated Statement of

3、 Financial Position中期簡明綜合財務狀況表67Interim Condensed Consolidated Statement of Changes in Equity中期簡明綜合權益變動表69Interim Condensed Consolidated Statement of Cash Flows中期簡明綜合現金流量表72Notes to Interim Condensed Consolidated Financial Information中期簡明綜合財務資料附註94Definitions and Glossary of Technical Terms釋義及技術詞匯Co

4、ntents目錄2Jiangsu Recbio Technology Co.,Ltd.江蘇瑞科生物技術股份有限公司Corporate Information公司資料DIRECTORSExecutive DirectorsDr.LIU Yong(Chairman of the Board and General Manager)Dr.CHEN JianpingMr.LI BuNon-Executive DirectorsDr.HONG KunxueDr.ZHOU HongbinMr.ZHAO HuiDr.DU WeiDr.FENG TaoIndependent Non-Executive Dir

5、ectorsMr.LIANG GuodongDr.XIA LijunProfessor GAO FengProfessor YUEN Ming FaiSUPERVISORSMs.QIAO Weiwei1(Chairman)Mr.WANG Feizhou2Ms.QIAN RantingMs.LIU Ping3JOINT COMPANY SECRETARIESMs.CHEN QingqingMs.HO Yin Kwan41 Ms.QIAO Weiwei was appointed as the chairwoman of the Supervisory Board on September 16,

6、2022,on the same date,Mr.CHEN Gang ceased to serve as the chairman of the Supervisory Board and a Supervisor.2 Mr.WANG Feizhou was appointed as a Supervisor on June 17,2022,on the same day,Mr.XU Yaming resigned as a Supervisor.3 Ms.LIU Ping was elected as a Supervisor on June 30,2022,on the same day